Seer (SEER) Other Non Operating Income (2024 - 2025)
Seer (SEER) recorded quarterly Other Non Operating Income of $3000.0 in Q2 2025, up 101.6% quarter-over-quarter from -$187000.0 in Q2 2024, and up 101.6% on a YoY basis from $1488.1 in Q2 2024.
Seer (SEER) Other Non Operating Income (2024 - 2025) Analysis & Trends
Seer's Other Non Operating Income history runs 2 years deep, the most recent figure standing at $3000.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2024 | -187,000.00 |